Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program

Pivotal studies of approved botulinum toxin type A (BoNTA) formulations for treatment of glabellar lines have mostly included treatment-naive participants, and the impact of prior BoNTA treatment on efficacy and safety is not well documented. OBJECTIVE: To evaluate whether prior BoNTA treatment affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Joel L., Green, Lawrence J., Beer, Kenneth R., Liu, Yan, Gallagher, Conor J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021231/
https://www.ncbi.nlm.nih.gov/pubmed/33587381
http://dx.doi.org/10.1097/DSS.0000000000002877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021231/
https://www.ncbi.nlm.nih.gov/pubmed/33587381
http://dx.doi.org/10.1097/DSS.0000000000002877

Ejemplares similares